At Conrad Pearson Clinic, advancing care for patients with complex urologic conditions has always been a top priority. We are proud to announce that our Advanced Prostate Cancer Clinic will soon begin offering Pluvicto™ infusion therapy, an innovative treatment designed for patients with advanced or metastatic prostate cancer.
With the first infusion scheduled to begin in the coming weeks, Conrad Pearson will be one of the only clinics in the Memphis region offering this cutting-edge therapy. This milestone reflects our commitment to bringing the most advanced prostate cancer treatments directly to patients in the Mid-South.
For patients and families facing advanced prostate cancer, this new option represents another step forward in delivering more targeted, personalized care close to home.
A New Era of Treatment for Advanced Prostate Cancer
Pluvicto is part of a new generation of treatments, designed to precisely target prostate cancer cells while minimizing exposure to surrounding healthy tissue.
This treatment works by combining a targeting molecule with a small amount of radioactive material. The therapy seeks out prostate cancer cells that express PSMA (prostate-specific membrane antigen) and delivers radiation directly to those cells.
This targeted approach helps:
- Attack cancer cells more precisely
- Slow disease progression
- Reduce damage to surrounding healthy tissue
- Provide an additional treatment option for patients with advanced disease
Therapies like Pluvicto are helping transform how advanced prostate cancer is treated, giving patients access to innovative therapies that were previously available only at major academic centers.
Why PSMA PET Imaging Matters
One of the key reasons Conrad Pearson is able to offer this advanced therapy is the clinic’s access to PSMA PET imaging, an advanced diagnostic tool used to identify prostate cancer cells throughout the body.
PSMA PET scan allows physicians to detect prostate cancer with remarkable accuracy by identifying cells that express PSMA. This imaging technology helps determine whether a patient is a candidate for Pluvicto therapy.
By combining advanced imaging with targeted therapy, physicians can design a treatment strategy that is highly personalized to each patient’s cancer.
At Conrad Pearson, this integration of diagnostics and treatment under one roof helps ensure patients receive efficient, coordinated care.
Infusion Therapy in a Dedicated Facility
Pluvicto treatments will be administered in the Nuclear Medicine Suite at Conrad Pearson’s Southwind office, where patients will be cared for by experienced clinical staff trained in handling these therapies safely and effectively.
This dedicated facility allows patients to receive treatment in a comfortable, specialized environment while remaining close to home.
By offering Pluvicto in-office, Conrad Pearson ensures patients can access advanced treatment without traveling outside the Memphis area.
Expanding Advanced Prostate Cancer Care in Memphis
Prostate cancer remains one of the most common cancers affecting men in the United States. While many cases are detected early and treated successfully, some patients develop advanced or metastatic prostate cancer, which requires more specialized treatment approaches.
Through its Advanced Prostate Cancer Clinic, Conrad Pearson focuses specifically on providing care for patients whose cancer requires additional expertise, advanced therapies, or multidisciplinary treatment planning. For eligible patients, Pluvicto can offer a promising additional line of treatment designed to target cancer cells more precisely.
Access to Innovative Care Close to Home
Patients in Memphis and throughout the Mid-South often travel long distances to access emerging cancer therapies. By introducing Pluvicto therapy locally, Conrad Pearson continues its mission to bring world-class urologic care to the region.
Being among the few providers in the Memphis area offering this treatment means patients can now receive advanced prostate cancer care without leaving the community where they live and receive ongoing medical support.
This approach reflects Conrad Pearson’s broader commitment to:
- Bringing new treatment technologies to the Mid-South
- Improving patient access to innovative therapies
- Delivering specialized prostate cancer care with compassion and expertise
What Patients Should Know
Not every patient with prostate cancer will be a candidate for Pluvicto therapy. Determining eligibility requires a thorough evaluation, including imaging with a PSMA PET scan and consultation with a prostate cancer specialist.
Patients diagnosed with advanced or metastatic prostate cancer who want to learn more about treatment options may benefit from speaking with a urologist who specializes in advanced disease management.
At Conrad Pearson, our physicians work closely with each patient to determine the most appropriate treatment plan based on:
- Cancer stage and progression
- Prior treatments
- Imaging results
- Overall health and treatment goals
Learn More About Advanced Prostate Cancer Treatment in Memphis
The addition of Pluvicto therapy represents another step forward in Conrad Pearson’s mission to deliver leading-edge urologic and prostate cancer care to patients throughout the Memphis region.
As the first infusion approaches, our team looks forward to offering this promising treatment to eligible patients through the Advanced Prostate Cancer Clinic.
If you or a loved one has been diagnosed with advanced prostate cancer and would like to explore available treatment options, the specialists at Conrad Pearson are here to help guide you through every step of your care.
To learn more about advanced prostate cancer treatment in Memphis or to schedule a consultation, visit the Conrad Pearson website or contact our office today.
